Spots Global Cancer Trial Database for stage iiic ovarian epithelial cancer

Every month we try and update this database with for stage iiic ovarian epithelial cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer	NCT00601406	Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer	gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera...	-	National Cancer Institute (NCI)
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer	NCT00964626	Ovarian Cancer	cisplatin paclitaxel	18 Years - 72 Years	National Cancer Institute (NCI)
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	NCT02122185	Brenner Tumor Malignant Ascit... Malignant Pleur... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Serous ... Ovarian Undiffe... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Ovaria... Stage IV Primar...	metformin hydro... placebo Chemotherapy	18 Years -	University of Chicago
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)	NCT00562640	Fallopian Tube ... Ovarian Cancer Primary Periton...	filgrastim therapeutic aut... cyclophosphamid... laboratory biom...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck	NCT00063895	Recurrent Non-s... Recurrent Ovari... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Non-sm... Stage IV Ovaria... Stage IV Squamo... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam...	erlotinib hydro... pharmacological... pharmacogenomic... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer	NCT02082470	Cancer Survivor Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar...	follow-up care active surveill... questionnaire a...	21 Years -	City of Hope Medical Center
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer	NCT01927393	Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Stage III Pancr... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre...	palliative care educational int... quality-of-life... questionnaire a... telephone-based...	21 Years -	City of Hope Medical Center
Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer	NCT02082470	Cancer Survivor Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar...	follow-up care active surveill... questionnaire a...	21 Years -	City of Hope Medical Center
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies	NCT00335998	Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Stage III Vagin... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIA Vulv... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIB Vulv... Stage IIIC Ovar... Stage IIIC Vulv... Stage IV Ovaria... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	triapine laboratory biom... external beam r... brachytherapy cisplatin pharmacological...	18 Years -	National Cancer Institute (NCI)
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen	NCT00305838	Fallopian Tube ... Ovarian Cancer Primary Periton...	tamoxifen citra... diagnostic labo...	-	National Cancer Institute (NCI)
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer	NCT00964626	Ovarian Cancer	cisplatin paclitaxel	18 Years - 72 Years	National Cancer Institute (NCI)
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00838656	Fallopian Tube ... Ovarian Cancer Primary Periton...	carboplatin gemcitabine hyd... paclitaxel	18 Years - 75 Years	National Cancer Institute (NCI)
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer	NCT00601406	Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer	gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera...	-	National Cancer Institute (NCI)
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer	NCT00900289	Ovarian Cancer	DNA methylation... microarray anal... polymerase chai... immunohistochem... laboratory biom...	18 Years -	Cancer Research UK, Glasgow
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer	NCT00075712	Fallopian Tube ... Ovarian Cancer Primary Periton...	carboplatin paclitaxel adjuvant therap... conventional su... neoadjuvant the...	18 Years -	National Cancer Institute (NCI)
Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer	NCT00004876	Ovarian Cancer	carboplatin thalidomide	18 Years -	National Cancer Institute (NCI)
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer	NCT00900289	Ovarian Cancer	DNA methylation... microarray anal... polymerase chai... immunohistochem... laboratory biom...	18 Years -	Cancer Research UK, Glasgow
Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	NCT00388037	Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	sunitinib malat... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer	NCT01212887	Breast Cancer Colorectal Canc... Gastric Cancer Lung Cancer Ovarian Cancer Pancreatic Canc... Unspecified Adu...	MFE23 scFv-expr... aldesleukin cyclophosphamid... fludarabine pho... laboratory biom... pharmacological...	18 Years -	Cancer Research UK
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen	NCT00305838	Fallopian Tube ... Ovarian Cancer Primary Periton...	tamoxifen citra... diagnostic labo...	-	National Cancer Institute (NCI)
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen	NCT00305838	Fallopian Tube ... Ovarian Cancer Primary Periton...	tamoxifen citra... diagnostic labo...	-	National Cancer Institute (NCI)
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer	NCT00986206	brca1 Mutation ... brca2 Mutation ... Ovarian Cancer	Biomarker LPA a...	18 Years - 95 Years	Women and Infants Hospital of Rhode Island
Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission	NCT00693342	Fallopian Tube ... Ovarian Cancer Primary Periton...	immunological a... polyvalent anti...	18 Years - 120 Years	GOG Foundation
Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer	NCT00303888	Fallopian Tube ... Ovarian Cancer Primary Periton...	docetaxel idronoxil placebo	18 Years - 120 Years	Yale University
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer	NCT01764802	Ovarian Sarcoma Ovarian Stromal... Stage I Uterine... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IA Endome... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IA Primar... Stage IB Cervic... Stage IB Endome... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IB Primar... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage IC Primar... Stage II Endome... Stage II Gestat... Stage II Uterin... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Prima... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Prima... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Prima... Stage III Gesta... Stage III Uteri... Stage III Vagin... Stage III Vulva... Stage IIIA Cerv... Stage IIIA Endo... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Cerv... Stage IIIB Endo... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Endo... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Breast Cancer	behavioral, psy... behavioral, psy...	21 Years - 80 Years	Ohio State University Comprehensive Cancer Center
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00897039	Fallopian Tube ... Ovarian Cancer Primary Periton...	flow cytometry immunohistochem...	-	National Cancer Institute (NCI)
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)	NCT00562640	Fallopian Tube ... Ovarian Cancer Primary Periton...	filgrastim therapeutic aut... cyclophosphamid... laboratory biom...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer	NCT02082470	Cancer Survivor Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar...	follow-up care active surveill... questionnaire a...	21 Years -	City of Hope Medical Center
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck	NCT00063895	Recurrent Non-s... Recurrent Ovari... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Non-sm... Stage IV Ovaria... Stage IV Squamo... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam...	erlotinib hydro... pharmacological... pharmacogenomic... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer	NCT00483782	Fallopian Tube ... Ovarian Cancer Primary Periton...	bevacizumab carboplatin paclitaxel questionnaire a... study of socioe... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer	NCT00045461	Fallopian Tube ... Ovarian Cancer Primary Periton...	carboplatin ifosfamide hyperthermia tr...	18 Years - 65 Years	National Cancer Institute (NCI)
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer	NCT00986206	brca1 Mutation ... brca2 Mutation ... Ovarian Cancer	Biomarker LPA a...	18 Years - 95 Years	Women and Infants Hospital of Rhode Island

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: